BRIACELL THERAPEUTICS CORP. (BCTXL) Capital expenditures 2024–2026
BRIACELL THERAPEUTICS CORP. (BCTXL) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$127,049FY2026 · since FY2024: $456,801 → $127,049
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $127,049 | — |
| FY2024 | $456,801 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More BCTXL financial trends
BCTXL RevenueBCTXL Net incomeBCTXL Net marginBCTXL Gross profitBCTXL Gross marginBCTXL Operating incomeBCTXL Operating marginBCTXL Operating cash flowBCTXL Free cash flowBCTXL Return on equityBCTXL Stock buybacksBCTXL Dividends paidBCTXL Total assetsBCTXL Total liabilitiesBCTXL Shareholders’ equityBCTXL overview →